Industry Leader’s Fireside Chat: Evaluating the CAR & TCR Therapeutic & Commercial Landscape to Propel Advanced Cell Therapy Innovation, Expand Treatment Options & Ensure Positive Commercial Outcomes

8:20 am - Wednesday 16th September 2026

  • Highlighting evolving modality innovations and industry shifts to demonstrate how rapid scientific and technological progress is enhancing treatment accessibility and reshaping the cell therapy landscape
  • Aligning clinical development, scalability and patient access strategies to accelerate commercialization pathways across advanced cell therapy modalities
  • Discussing post-approval reimbursement policies and strategies to ensure long-term commercial success
  • Predicting cell therapy evolution through 2026 and beyond to provide strategic and commercial foresight

Speakers:

Vicki Plaks
Senior Director, Scientific, Head of Cell Therapy, Oncology Translational Research
Johnson & Johnson
Emad Abdelnaby
Senior Vice President - Head of Commercial
Legend Biotech
Serena De Vita
Vice President, Global Franchise Head & Clinical Strategy Head, Late Development Oncology, Cell Therapy, ORD
AstraZeneca